How long does NM-2-AI last?

The total duration of NM-2-AI via oral is 2 hours to 4 hours. Onset typically occurs within 30 minutes to 1 hour.

NM-2-AI — SubstanceWiki

N-Methyl-2-aminoindane (NM-2-AI) is a synthetic stimulant of the aminoindane chemical class — the N-methyl derivative of 2-aminoindane (2-AI). By adding an N-methyl group to the primary amine of 2-AI, NM-2-AI occupies a structural position analogous to the methamphetamine/amphetamine relationship: an increase in lipophilicity and CNS penetrance expected to enhance potency and extend duration relative to the parent compound.

Like 2-AI, NM-2-AI is classified as a stimulant within the aminoindane family, believed to act primarily through dopamine and norepinephrine releasing activity with minimal serotonergic activity. The compound has been proposed to share 2-AI's purported non-neurotoxic profile (based on structural inference and limited animal data), but this claim is even less rigorously established for NM-2-AI than for 2-AI itself.

NM-2-AI remains one of the less-documented stimulant research chemicals. Community experience data are sparse, and the compound has attracted less attention than the more widely used fluorinated amphetamines or classic phenidates. The limited data available describe it as a mild-to-moderate stimulant with a generally clean, low-side-effect profile at typical doses — consistent with the aminoindane class character. However, the dose-response curve and upper limits of safe dosing are essentially uncharacterized.

How It Feels

NM-2-AI makes its presence known gradually and without fanfare. Within thirty to sixty minutes of oral ingestion, a gentle stimulation begins to emerge. It is a quiet compound, lacking the dramatic onset or pronounced euphoria of cathinone stimulants. Instead, there is a clean, steady increase in alertness and a mild elevation of mood that feels closer to the effect of a successful nap than to recreational drug use. The body warms slightly, and there is a subtle but real sense of increased energy and motivation.

At the peak, reached around one to two hours in, NM-2-AI provides a moderate, functional stimulation with a notably smooth character. The mind is clear and attentive. Focus is improved, though not to the degree offered by dedicated cognitive enhancers. The mood is gently positive, and there is an easygoing sociability that makes the compound suitable for social situations without making it particularly remarkable in that context. There is a physical warmth and lightness to the body that feels pleasant but unobtrusive. The overall experience occupies a middle ground between the functional austerity of phenidates and the emotional warmth of cathinones, without fully committing to either character.

Physical effects are mild. Heart rate may increase slightly, appetite is modestly suppressed, and there is a barely perceptible jaw tension. The aminoindane structure lends itself to a smoother, less physiologically aggressive profile than the cathinones, and users generally report feeling physically comfortable throughout. There is no significant vasoconstriction, no temperature dysregulation, and no pronounced sweating. The body functions normally within a slightly elevated range.

The effects last three to five hours and taper without incident. The comedown is among the gentlest of any stimulant: a gradual return of baseline fatigue and mood without any acute crash, emotional deficit, or rebound. Sleep is achievable within a reasonable timeframe. The following morning is unremarkable. The total impression of NM-2-AI is one of pleasant mediocrity, a compound that offers enough to justify its existence but not enough to generate enthusiasm. It is functional, tolerable, and forgettable in roughly equal measure.

Interactions

Substance	Status	Note
25x-NBOH	Dangerous	—
25x-NBOMe	Dangerous	—
Atropa belladonna	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Datura	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Diphenhydramine	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Harmala alkaloid	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Peganum harmala	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
MDMA	Unsafe	—
1,3-Butanediol	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25E-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-2	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-21	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-7	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
3-FMA	Caution	Increased cardiovascular strain and neurotoxicity risk
4-MMC	Caution	Increased cardiovascular strain and neurotoxicity risk
8-Chlorotheophylline	Caution	Increased cardiovascular strain and neurotoxicity risk
Adrafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
Allylescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Ayahuasca	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Benzydamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Bromantane	Caution	Increased cardiovascular strain and neurotoxicity risk
Cake	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Deschloroetizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Desomorphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
DET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Dichloropane	Caution	Increased cardiovascular strain and neurotoxicity risk
Diclazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOM	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Efavirenz	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Ephedrine	Caution	Increased cardiovascular strain and neurotoxicity risk
EPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Eszopiclone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Etizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flubromazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flubromazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flunitrazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flunitrazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Gaboxadol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Hexedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Ibogaine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Lorazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Mephenaqualone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
MET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methallylescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methcathinone	Caution	Increased cardiovascular strain and neurotoxicity risk
Metizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Midazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
MPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Naloxone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Nicotine	Caution	Increased cardiovascular strain and neurotoxicity risk
Nifoxipam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Oxiracetam	Caution	Increased cardiovascular strain and neurotoxicity risk
Pentobarbital	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Phenobarbital	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Phenylpiracetam	Caution	Increased cardiovascular strain and neurotoxicity risk
Psilocybin Mushrooms	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increased cardiovascular strain and neurotoxicity risk
SAMe	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Alcohol	Uncertain	—

Showing 63 key interactions out of 64 total.

Toxicity & Safety

Overview

NM-2-AI's toxicity profile is essentially undocumented in formal literature. Like 2-AI, the primary risks are cardiovascular and psychological, consistent with a dopaminergic/noradrenergic stimulant. The N-methyl modification likely increases potency and potentially the cardiovascular activation per dose relative to 2-AI.

Neurotoxicity Assessment

Based on structural class and proposed mechanism (primarily dopaminergic/noradrenergic, minimal serotonergic activity), NM-2-AI likely lacks the specific serotonergic neurotoxicity associated with para-substituted amphetamines. However, structural inference is not equivalent to safety data. Chronic high-dose use of any dopaminergic releasing agent can produce dopaminergic neurotoxicity.

Cardiovascular Risk

Standard sympathomimetic cardiovascular risks — tachycardia, elevated blood pressure — apply. Potency increase from N-methylation means these effects may be more pronounced per milligram than with 2-AI.

Data Gap Warning

NM-2-AI represents a compound where the risk is genuinely unknown rather than "probably comparable to X." The sparse community experience means dose thresholds for toxicity, maximum safe doses, and interaction risks are undocumented.

Addiction Potential

moderately addictive with a high potential for abuse

Overdose Information

Stimulant overdose from NM-2-AI is a medical emergency primarily involving cardiovascular and neurological toxicity.

Signs of overdose: Extremely rapid or irregular heartbeat, chest pain, severe headache, dangerously elevated body temperature, seizures, agitation progressing to psychosis, confusion, and loss of consciousness.Emergency response:

Call emergency services immediately
Keep the person cool (remove excess clothing, apply cool water)
If seizures occur, protect the head and clear the area of hard objects
If the person loses consciousness, place in recovery position
Do not give the person more stimulants, caffeine, or depressants unless directed by medical professionalsPrevention: Pre-measure doses. Avoid redosing. Stay hydrated (but don't overhydrate). Take breaks from physical activity. Monitor heart rate if possible. Have someone present who can recognize warning signs.

Full	develops with prolonged and repeated use
Half	3 - 7 days
Zero	1 - 2 weeks

NM-2-AI

Quick Dosage

Dosage

oral

Duration

oral

How It Feels

Subjective Effects

Physical Effects

Physical(7)

Cognitive & Perceptual Effects

Cognitive(10)

Pharmacology

Mechanism of Action

Receptor Profile

Comparison to 2-AI

Pharmacokinetics

Detection Methods

Standard Drug Panel Inclusion

Urine Detection

Blood and Saliva Detection

Hair Follicle Detection

Confirmatory Testing

Reagent Testing

Interactions

History

Origins in Aminoindane Chemistry

Research Chemical Market

Regulatory Status

Harm Reduction

Start Low and Go Slow

Do Not Combine with MAOIs

Avoid Other Stimulants

Accept Data Limitations

Oral Route Only

Toxicity & Safety

Overview

Neurotoxicity Assessment

Cardiovascular Risk

Data Gap Warning

Addiction Potential

Overdose Information

Dangerous Interactions

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (5)

See Also

References (5)

Frequently Asked Questions